Fortress Biotech Inc (FBIO)
1.73
+0.06
(+3.59%)
USD |
NASDAQ |
May 01, 16:00
1.73
0.00 (0.00%)
After-Hours: 17:26
Fortress Biotech Price to Book Value: 1.476 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 1.425 |
| April 29, 2024 | 1.468 |
| April 26, 2024 | 1.468 |
| April 25, 2024 | 1.468 |
| April 24, 2024 | 1.527 |
| April 23, 2024 | 1.544 |
| April 22, 2024 | 1.493 |
| April 19, 2024 | 1.493 |
| April 18, 2024 | 1.544 |
| April 17, 2024 | 1.510 |
| April 16, 2024 | 1.502 |
| April 15, 2024 | 1.553 |
| April 12, 2024 | 1.536 |
| April 11, 2024 | 1.553 |
| April 10, 2024 | 1.630 |
| April 09, 2024 | 1.613 |
| April 08, 2024 | 1.621 |
| April 05, 2024 | 1.596 |
| April 04, 2024 | 1.596 |
| April 03, 2024 | 1.638 |
| April 02, 2024 | 1.647 |
| April 01, 2024 | 1.698 |
| March 28, 2024 | 1.707 |
| March 27, 2024 | 1.852 |
| March 26, 2024 | 1.574 |
| Date | Value |
|---|---|
| March 25, 2024 | 1.557 |
| March 22, 2024 | 1.578 |
| March 21, 2024 | 1.606 |
| March 20, 2024 | 1.557 |
| March 19, 2024 | 1.545 |
| March 18, 2024 | 1.565 |
| March 15, 2024 | 1.578 |
| March 14, 2024 | 1.370 |
| March 13, 2024 | 1.484 |
| March 12, 2024 | 1.569 |
| March 11, 2024 | 1.630 |
| March 08, 2024 | 1.712 |
| March 07, 2024 | 1.688 |
| March 06, 2024 | 1.806 |
| March 05, 2024 | 1.851 |
| March 04, 2024 | 1.867 |
| March 01, 2024 | 1.981 |
| February 29, 2024 | 1.696 |
| February 28, 2024 | 1.777 |
| February 27, 2024 | 1.614 |
| February 26, 2024 | 1.508 |
| February 23, 2024 | 1.419 |
| February 22, 2024 | 1.427 |
| February 21, 2024 | 1.410 |
| February 20, 2024 | 1.451 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7027
Minimum
Nov 10 2023
8.359
Maximum
Feb 14 2020
3.094
Average
2.862
Median
Price to Book Value Benchmarks
| Journey Medical Corp | 3.507 |
| Avenue Therapeutics Inc | 1.831 |
| Checkpoint Therapeutics Inc | -- |
| Viking Therapeutics Inc | 9.021 |
| Mustang Bio Inc | 21.71 |
Price to Book Value Related Metrics
| PS Ratio | 0.1660 |
| Price | 1.73 |
| Earnings Yield | -474.9% |
| Market Cap | 33.28M |